Abbvie (ABBV) PT Raised to $120 at JPMorgan
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $249.46 -0.54%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Chris Schott raised the price target on Abbvie (NYSE: ABBV) to $120.00 (from $115.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
